Clean Science and Technology showed resilient performance in Q1 FY27. Consolidated revenue hit an all-time high of 268 Cr, up 11% year-on-year, while consolidated profit after tax (PAT) grew 5% to 73 Cr.

Standalone revenue was 207 Cr and standalone PAT was 73 Cr.

The performance chemicals segment was a key contributor, with its share increasing due to higher HALS series sales, de-risking product concentration.

The company is strategically expanding its global footprint by establishing a wholly-owned European subsidiary to boost market engagement.

It also incurred ~100 Cr capex in Q1 for its subsidiary, Clean Fino Chem.

A strategic collaboration with a Swiss tech partner aims to accelerate advanced HALS development.

Management is focused on commercializing Performance Chemical 2 by Q3 FY27 and adding new high-value products through greenfield capex and new chemistries.